Yasuhiro Matsumura Selected Research

Yasuhiro Matsumura Research Topics

Disease

83	Neoplasms (Cancer) 05/2024 - 04/2002
27	Colorectal Neoplasms (Colorectal Cancer) 03/2021 - 01/2002
17	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 09/2004
15	Stomach Neoplasms (Stomach Cancer) 05/2021 - 10/2002
8	Neoplasm Metastasis (Metastasis) 07/2016 - 03/2003
6	Inflammation (Inflammations) 06/2023 - 07/2004
6	Asthma (Bronchial Asthma) 06/2023 - 09/2002
5	Esophageal Squamous Cell Carcinoma 05/2024 - 02/2017
4	Glioblastoma (Glioblastoma Multiforme) 07/2022 - 06/2009
4	Colonic Neoplasms (Colon Cancer) 10/2021 - 10/2002
4	Body Weight (Weight, Body) 05/2021 - 12/2003
4	Neutropenia 12/2018 - 05/2010
4	Hemorrhage 01/2018 - 11/2002
3	Disease Progression 01/2019 - 08/2012
3	Diarrhea 12/2018 - 12/2010
3	Glioma (Gliomas) 01/2017 - 06/2009
2	Adenocarcinoma of Lung 06/2018 - 10/2010
2	Cardiotoxicity 07/2014 - 07/2013
2	Obesity 07/2013 - 03/2010
2	Lymphoma (Lymphomas) 02/2013 - 09/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2010 - 03/2003
2	Overactive Urinary Bladder (Overactive Bladder) 05/2009 - 03/2008
2	Breast Neoplasms (Breast Cancer) 01/2007 - 07/2004
2	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2006 - 03/2004
2	Xeroderma Pigmentosum (Kaposi's Disease) 09/2005 - 07/2004
2	Carcinogenesis 08/2004 - 07/2004
2	Vomiting 08/2003 - 06/2003
2	Fatigue 08/2003 - 06/2003
1	Esophageal Neoplasms (Esophageal Cancer) 10/2021

Drug/Important Bio-Agent (IBA)

28	MicellesIBA 10/2020 - 10/2002
24	Irinotecan (Camptosar)FDA LinkGeneric 11/2019 - 08/2003
18	Thromboplastin (Tissue Factor)IBA 01/2022 - 09/2011
16	Monoclonal AntibodiesIBA 07/2022 - 07/2004
12	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 10/2006
11	Immunoconjugates (Immunoconjugate)IBA 07/2022 - 07/2011
10	FibrinIBA 01/2022 - 07/2011
9	Proteins (Proteins, Gene)FDA Link 10/2021 - 10/2011
7	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 09/2005
6	AntibodiesIBA 07/2022 - 06/2012
6	NC 6300IBA 10/2020 - 07/2013
6	Cisplatin (Platino)FDA LinkGeneric 12/2016 - 12/2003
6	Fluorouracil (Carac)FDA LinkGeneric 05/2008 - 01/2002
5	AntigensIBA 07/2022 - 06/2012
5	Messenger RNA (mRNA)IBA 11/2018 - 09/2002
5	NK105IBA 12/2016 - 05/2008
4	NivolumabIBA 05/2024 - 10/2021
4	GlucocorticoidsIBA 06/2023 - 09/2002
4	Liposomes (Liposome)IBA 10/2020 - 10/2002
4	Cytotoxins (Cytolysins)IBA 01/2017 - 02/2006
4	Paclitaxel (Taxol)FDA LinkGeneric 12/2016 - 12/2008
4	Epirubicin (Ellence)FDA LinkGeneric 03/2016 - 07/2013
4	LuciferasesIBA 08/2010 - 01/2008
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2018 - 05/2006
3	Immunoglobulin G (IgG)IBA 01/2017 - 12/2014
3	PlatinumIBA 01/2015 - 01/2009
3	RNA (Ribonucleic Acid)IBA 01/2014 - 11/2007
3	CollagenIBA 02/2013 - 07/2011
3	ProdrugsIBA 12/2010 - 06/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2009 - 10/2006
2	B7-H1 AntigenIBA 05/2024 - 01/2023
2	IpilimumabIBA 05/2024 - 01/2023
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 06/2023 - 09/2002
2	EnzymesIBA 10/2021 - 10/2015
2	Oxygen (Dioxygen)IBA 10/2021 - 02/2019
2	monomethyl auristatin EIBA 01/2021 - 04/2016
2	Immunoglobulin Fab FragmentsIBA 10/2020 - 12/2015
2	AnticoagulantsIBA 01/2020 - 01/2018
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2020 - 01/2018
2	Protein SIBA 01/2020 - 01/2018
2	Thrombin FDA Link 01/2020 - 01/2018
2	Immunoglobulin FragmentsIBA 11/2018 - 01/2015
2	Small Interfering RNA (siRNA)IBA 11/2018 - 08/2010
2	Tyrosine Kinase InhibitorsIBA 06/2018 - 10/2015
2	demplatin pegraglumerIBA 12/2016 - 06/2014
2	Drug CarriersIBA 07/2016 - 10/2002
2	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 10/2015 - 12/2010
2	MicroRNAs (MicroRNA)IBA 10/2013 - 11/2010
2	Topoisomerase I InhibitorsIBA 02/2013 - 09/2011
2	EstersIBA 02/2013 - 09/2011
2	Therapeutic UsesIBA 02/2013 - 05/2008
2	Carboxylesterase (Hydrolase S)IBA 02/2013 - 08/2010
2	Bevacizumab (Avastin)FDA Link 10/2010 - 01/2010
2	Gemcitabine FDA Link 02/2010 - 09/2004
2	PolymersIBA 04/2009 - 12/2003
2	A-Form DNA (A-DNA)IBA 01/2009 - 12/2007
2	Stem Cell FactorIBA 09/2005 - 07/2004
2	Complementary DNA (cDNA)IBA 08/2004 - 03/2003
2	liposomal doxorubicin (Doxil)FDA Link 07/2004 - 10/2002
2	KRN 5500 (KRN5500)IBA 06/2003 - 11/2002
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 10/2021
1	Glutamine (L-Glutamine)FDA Link 10/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2021
1	Fc Receptors (Fc Receptor)IBA 08/2021
1	Chimeric Antigen ReceptorsIBA 08/2021
1	SolutionsIBA 05/2021

Therapy/Procedure

34	Therapeutics 01/2022 - 09/2002
20	Drug Therapy (Chemotherapy) 05/2024 - 01/2002
2	Radiotherapy 01/2022 - 11/2005
2	Radioimmunotherapy 01/2022 - 06/2021